Warrant Liabilities (Details) $ / shares in Thousands, $ in Thousands |
12 Months Ended | ||||
|---|---|---|---|---|---|
|
Dec. 31, 2025
USD ($)
shares
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
shares
|
Oct. 31, 2021
shares
|
Dec. 31, 2019
$ / shares
|
|
| Warrant Liabilities [Line Items] | |||||
| Warrants | $ | $ 493 | ||||
| Warrants [Member] | |||||
| Warrant Liabilities [Line Items] | |||||
| Aggregate exercise price | $ / shares | $ 550 | ||||
| Cashless exercise shares | 227,959 | ||||
| Number of private placement warrants | 106,414 | ||||
| Fair value of warrants | $ | $ 11 | ||||
| Warrants | $ | $ 297 | $ 447 | $ 756 | ||
| Volatility [Member] | |||||
| Warrant Liabilities [Line Items] | |||||
| Warrants’ fair value measurement input | 5 | ||||
| Private Placement [Member] | Warrants [Member] | |||||
| Warrant Liabilities [Line Items] | |||||
| Number of private placement warrants | 3,112,080 | ||||
| Ordinary Shares [Member] | |||||
| Warrant Liabilities [Line Items] | |||||
| Cashless exercise shares | 106,414 | ||||
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|